These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38741700)

  • 1. Proteomic Analysis of Primary Graft Dysfunction in Porcine Lung Transplantation Reveals Alveolar-Capillary Barrier Changes Underlying the High Particle Flow Rate in Exhaled Breath.
    Niroomand A; Hirdman G; Bèchet N; Ghaidan H; Stenlo M; Kjellström S; Isaksson M; Broberg E; Pierre L; Hyllén S; Olm F; Lindstedt S
    Transpl Int; 2024; 37():12298. PubMed ID: 38741700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early protein expression profile in bronchoalveolar lavage fluid and clinical outcomes in primary graft dysfunction after lung transplantation.
    Frick AE; Verleden SE; Ordies S; Sacreas A; Vos R; Verleden GM; Vanaudenaerde BM; Claes S; Schols D; Van Raemdonck DE; Neyrinck AP
    Eur J Cardiothorac Surg; 2020 Aug; 58(2):379-388. PubMed ID: 32267918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential proteomic analysis of bronchoalveolar lavage fluid from lung transplant patients with and without chronic graft dysfunction.
    Kosanam H; Sato M; Batruch I; Smith C; Keshavjee S; Liu M; Diamandis EP
    Clin Biochem; 2012 Feb; 45(3):223-30. PubMed ID: 22206736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local complement activation is associated with primary graft dysfunction after lung transplantation.
    Kulkarni HS; Ramphal K; Ma L; Brown M; Oyster M; Speckhart KN; Takahashi T; Byers DE; Porteous MK; Kalman L; Hachem RR; Rushefski M; McPhatter J; Cano M; Kreisel D; Scavuzzo M; Mittler B; Cantu E; Pilely K; Garred P; Christie JD; Atkinson JP; Gelman AE; Diamond JM
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32750037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volatile organic compound profiling to explore primary graft dysfunction after lung transplantation.
    Stefanuto PH; Romano R; Rees CA; Nasir M; Thakuria L; Simon A; Reed AK; Marczin N; Hill JE
    Sci Rep; 2022 Feb; 12(1):2053. PubMed ID: 35136125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant role for microRNA-21 affecting toll-like receptor pathway in primary graft dysfunction after human lung transplantation.
    Xu Z; Sharma M; Gelman A; Hachem R; Mohanakumar T
    J Heart Lung Transplant; 2017 Mar; 36(3):331-339. PubMed ID: 27773452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lung microbiota in primary graft dysfunction in lung transplant recipients.
    Wu Y; Huang L; Li M; Cui X; Zhan Q; Wang C
    Clin Transplant; 2023 Dec; 37(12):e15152. PubMed ID: 37788167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation.
    Truby LK; Kwee LC; Agarwal R; Grass E; DeVore AD; Patel CB; Chen D; Schroder JN; Bowles D; Milano CA; Shah SH; Holley CL
    J Heart Lung Transplant; 2021 Dec; 40(12):1589-1598. PubMed ID: 34511330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
    DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantation.
    Somers J; Ruttens D; Verleden SE; Vandermeulen E; Piloni D; Wauters E; Lambrechts D; Vos R; Verleden GM; Vanaudenaerde B; van Raemdonck DE
    J Heart Lung Transplant; 2015 Jul; 34(7):941-9. PubMed ID: 25935436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant endothelin-1 overexpression in lung transplant donors and recipients predicts primary graft dysfunction.
    Salama M; Andrukhova O; Hoda MA; Taghavi S; Jaksch P; Heinze G; Klepetko W; Aharinejad S
    Am J Transplant; 2010 Mar; 10(3):628-36. PubMed ID: 20055806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients.
    Bhimji A; Bhaskaran A; Singer LG; Kumar D; Humar A; Pavan R; Lipton J; Kuruvilla J; Schuh A; Yee K; Minden MD; Schimmer A; Rotstein C; Keshavjee S; Mazzulli T; Husain S
    Clin Microbiol Infect; 2018 Jun; 24(6):640-645. PubMed ID: 28970160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-inflammatory IgG1 N-glycan signature correlates with primary graft dysfunction onset in COPD patients.
    McQuiston A; Scott D; Nord D; Langerude L; Pelaez A; Machuca T; Mehta A; Drake RR; Christie JD; Angel P; Atkinson C
    Transpl Immunol; 2022 Apr; 71():101491. PubMed ID: 34767945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.
    Abbas AA; Diamond JM; Chehoud C; Chang B; Kotzin JJ; Young JC; Imai I; Haas AR; Cantu E; Lederer DJ; Meyer KC; Milewski RK; Olthoff KM; Shaked A; Christie JD; Bushman FD; Collman RG
    Am J Transplant; 2017 May; 17(5):1313-1324. PubMed ID: 27731934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome.
    Van Slambrouck J; Van Raemdonck D; Vos R; Vanluyten C; Vanstapel A; Prisciandaro E; Willems L; Orlitová M; Kaes J; Jin X; Jansen Y; Verleden GM; Neyrinck AP; Vanaudenaerde BM; Ceulemans LJ
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
    Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
    J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mechanical ventilation in primary graft dysfunction in the postoperative lung transplant recipient: A single center study and literature review.
    Niroomand A; Qvarnström S; Stenlo M; Malmsjö M; Ingemansson R; Hyllén S; Lindstedt S
    Acta Anaesthesiol Scand; 2022 Apr; 66(4):483-496. PubMed ID: 35014027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particle Flow Profiles From the Airways Measured by PExA Differ in Lung Transplant Recipients Who Develop Primary Graft Dysfunction.
    Broberg E; Hyllén S; Algotsson L; Wagner DE; Lindstedt S
    Exp Clin Transplant; 2019 Dec; 17(6):803-812. PubMed ID: 31615381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of sex-based differences in clinical and molecular responses to ischemia reperfusion after lung transplantation.
    Chacon-Alberty L; Ye S; Daoud D; Frankel WC; Virk H; Mase J; Hochman-Mendez C; Li M; Sampaio LC; Taylor DA; Loor G
    Respir Res; 2021 Dec; 22(1):318. PubMed ID: 34937545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.